Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRIPT trial
PACTR201101000273931Unknown
- Sponsor
- Christian Wejse
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of isoniazid and rifampicin in Tuberculosis (TB) (2 arms), sponsored by Christian Wejse. Primary endpoint: Adherence to therapy. Status: unknown.
02
Drugs
isoniazidrifampicin
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on PACTR201101000273931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201101000273931.